5G SHIFT employs Open RAN (O-RAN) fronthaul technology in its Radio Units (O-RUs) running on RANsemi 5G PHY SoCs to enhance in-building wireless coverage. The Antevia 5G SHIFT platform, based on a virtualised radio access network (vRAN) architecture that deploys a 'shared cell' topology, is currently running in live public trials in multiple locations across the United Kingdom.
According to Peter Claydon, CEO of RANsemi, "It's fantastic to see our silicon being deployed locally through our successful partnership with Antevia, which has brought two innovative British technology companies together in collaboration. Enterprises need readily deployable, cost-effective, yet easily adaptable private network platforms and 5G SHIFT delivers. We are proud to be part of this exciting innovation with Antevia O-RUs running on RANsemi SoCs."
The 5G SHIFT platform is ready for deployment in critical environments where reliability is essential, such as retail locations that require reliable and secure connectivity.
Public 5G SHIFT trials are taking place at Bath Rugby Ground and the historic Roman Baths, located in Bath, England, along with Cardiff Market, Cardiff, Wales. For these deployments, Antevia Networks has provided its O-RUs running on RANsemi silicon with its Fronthaul Multiplexer (FHM), which creates a 'shared cell' configuration so that a network of many O-RUs behaves like a single virtual cell - this eliminates the complex planning required to manage handovers and interference.
"Enterprises are eager for fast, simple, and secure 5G private networks,” said Simon Cosgrove, CEO of Antevia Networks. “By establishing our O-RUs on RANsemi silicon, leveraging the open, flexible architecture based on O-RAN standards, combined with vRAN, we can deliver cost-effective, intelligent, cloud-based 5G private networks optimised for indoor deployments.”
Antevia Networks will showcase its ecosystem of partners, including RANsemi, around 5G SHIFT and demonstrate the platform at next month’s MWC Barcelona in Hall 7, 7A9 in the UK Pavilion.